Medical update: Hormone receptor-positive metastatic breast cancer

Hormone receptor-positive metastatic breast cancers test positive for estrogen (ER-positive) or progesterone (PR-positive) receptors, or both, and often respond to anti-estrogen therapies. This session details FDA approved and pipeline hormonal therapies, targeted therapies, and chemotherapy regimens that are used in metastatic disease, as well as ways to manage common side effects.